文献速递脑血管病外科神经重症

脑周池性与非脑周池性蛛网膜下腔出血患者的临床结局与预后因素

Clinical Outcome and Prognostic Factors of Patients with Perimesencephalic and Nonperimesencephalic Subarachnoid Hemorrhage.
PubMed 文献 · World Neurosurg · 2022-06-24

该回顾性研究纳入2009至2018年本院608例确诊蛛网膜下腔出血患者,其中动脉瘤性占78%、非动脉瘤性占22%。非动脉瘤性中脑周池性占30%、非脑周池性占70%。非脑周池性与动脉瘤性30天死亡率无显著差异(29% vs 28%,P=0.835),初始Hunt-Hess评分是两者不良结局的重要预测因素。

要点

  • 非脑周池性蛛网膜下腔出血的临床结局与动脉瘤性相似,尽管临床并发症显著更少。
  • 脑周池性蛛网膜下腔出血患者整体临床病程良好。
  • 初始Hunt-Hess评分是动脉瘤性和非脑周池性蛛网膜下腔出血不良结局的重要预测因素。

核心结论

  • 非脑周池性蛛网膜下腔出血患者临床结局与动脉瘤性蛛网膜下腔出血相似,尽管非脑周池性患者临床并发症显著更少。
  • 脑周池性蛛网膜下腔出血患者整体临床病程良好。
  • 多变量分析显示初始Hunt-Hess评分是动脉瘤性及非脑周池性蛛网膜下腔出血临床结局的重要预测因素。

研究设计与样本

  • 回顾性识别2009年至2018年在本院就诊的蛛网膜下腔出血患者,分析人口学与临床数据及结局,并对结局参数进行多变量分析。
  • 共纳入608例确诊蛛网膜下腔出血患者,其中78%为动脉瘤性、22%为非动脉瘤性;非动脉瘤性中脑周池性占30%、非脑周池性占70%。

主要发现

  • 动脉瘤性蛛网膜下腔出血患者初始临床状态(Hunt-Hess评分)显著差于非动脉瘤性患者。
  • 延迟性脑缺血等并发症在动脉瘤性蛛网膜下腔出血患者中显著更常见。
  • 脑周池性蛛网膜下腔出血患者临床病程优于动脉瘤性或非脑周池性患者。
  • 动脉瘤性(29%)与非脑周池性(28%)患者30天死亡率无显著差异(P=0.835)。
  • 多变量回归中Hunt-Hess评分是动脉瘤性和非脑周池性蛛网膜下腔出血不良结局的强预测因素。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To demonstrate the clinical outcome of patients with nonperimesencephalic subarachnoid hemorrhage (npSAH) compared with patients with aneurysmal SAH (aSAH) and perimesencephalic SAH (pSAH) and to evaluate predictive value of various clinical and radiological findings in patients with npSAH. METHODS: We retrospectively identified patients with SAH who presented at our institution between 2009 and 2018. We analyzed demographic and clinical data and outcomes. Multivariable analysis was performed for outcome parameters. RESULTS: Of 608 patients with confirmed SAH, 78% had aSAH, and 22% had nonaneurysmal SAH. Nonaneurysmal SAH was perimesencephalic in 30% of cases and nonperimesencephalic in 70%. Initial clinical status (Hunt and Hess score) was significantly worse in patients with aSAH compared with patients with nonaneurysmal SAH. Complications such as delayed cerebral ischemia occurred significantly more often in patients with aSAH. Patients with pSAH had a more favorable clinical course than patients with aSAH or npSAH. There was no significant difference in 30-day mortality between aSAH (29%) and npSAH (28%) patients (P = 0.835). Hunt and Hess score emerged as a strong predictor of unfavorable outcome in both aSAH and npSAH in multivariable regression. CONCLUSIONS: Patients with npSAH had a similar clinical outcome as patients with aSAH, although there were significantly fewer clinical complications in patients with npSAH. Patients with pSAH demonstrated an overall good clinical course. Our multivariable analysis showed that initial Hunt and Hess score was an important predictor for clinical outcome in aSAH as well as npSAH.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Angermann M, Jablawi F, Angermann M, et al. Clinical Outcome and Prognostic Factors of Patients with Perimesencephalic and Nonperimesencephalic Subarachnoid Hemorrhage. World Neurosurg. 2022. PMID: 35753679. doi:10.1016/j.wneu.2022.06.086

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。